Tuvusertib-Based Combinations to Overcome PARP Inhibitor Resistance | 2025 BRCA Scientific Symposium
Автор: Dana-Farber Cancer Institute
Загружено: 2025-12-19
Просмотров: 12
Ioannis Gounaris, MD, PhD, of Merck, discusses tuvusertib-based combinations to overcome PARP inhibitor resistance at the 2025 Dana-Farber Cancer Institute Center for BRCA and Related Genes Scientific Symposium.
For more information about the Center for BRCA and Related Genes, please visit https://www.dana-farber.org/cancer-ca...
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: